Acronimo 70RA1NociP

Abstract The term “nociplastic pain” was introduced by the IASP in 2017 as a third mechanistic pain descriptor in addition to nociceptive and neuropathic pain. Nociplastic pain has been defined as “pain that arises from altered nociception despite no clear evidence of actual or threatened tissue damage causing the activation of peripheral nociceptors or evidence for disease or lesion of the somatosensory system causing the pain.” Recently, a IASP task force developed a set of clinical criteria and a grading system for nociplastic pain affecting the musculoskeletal system. The proposal has great potential, especially in addressing the treatment of people with chronic pain. Both the clinical criteria and grading system need to be validated and further developed. Two weaknesses can be identified; 1) the clinical applicability is limited by the time-consuming procedures, 2) the criteria that define the somatic distribution of pain appears to be not objective and oversimplified. The aim of this study is to establish if pain drawings analysis can predict the grading of neoplastic pain.

Enti SUPSI coinvolti Laboratorio di ricerca in riabilitazione 2rLab

Persone coinvolte Matteo Beretta Piccoli, Ruth Hersche-Cupelli, Alessandro Schneebeli, Corrado Cescon, Cinzia Cruder, Anna Folli

Responsabili Marco Barbero

Data di inizio progetto 1 gennaio 2022

Data di chiusura progetto 31 dicembre 2022